Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Omega-DEK in Childhood Apraxia of Speech

NCT07216001 is registered in ClinicalTrials.gov with Claudia R. Morris as lead sponsor.

NCT NCT07216001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07216001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Omega-DEK in Childhood Apraxia of Speech
Lead sponsor
Claudia R. Morris
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
December 31, 2027
Enrollment
34 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autism, childhood apraxia of speech, verbal apraxia